comparemela.com

Latest Breaking News On - Biosciences stock down - Page 4 : comparemela.com

Westfield Capital Management Co. LP Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Westfield Capital Management Co. LP reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 8.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 594,437 shares of the company’s stock after selling 54,855 shares during the quarter. Westfield Capital Management Co. […]

United-states
Lesliev-norwalk
Neurocrine-biosciences
Ingrid-delaet
Cantor-fitzgerald
Lindbrook-capital
Edgerock-capital
Sunbelt-securities-inc
Nasdaq
Canaccord-genuity-group
Westfield-capital-management-co
Benjaminf-edwards-company-inc

Simplicity Wealth LLC Makes New $162,000 Investment in Ventyx Biosciences, Inc. (NASDAQ:VTYX)

Simplicity Wealth LLC acquired a new position in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 29,405 shares of the company’s stock, valued at approximately $162,000. Other large investors have also modified their […]

Ventyx-biosciences
Ventyx-biosciences-company-profile
Canaccord-genuity-group
Securities-exchange-commission
Tower-research-capital
Nasdaq
Norden-group
Hermes-inc
Wells-fargo-company
Simplicity-wealth
Ventyx-biosciences-inc
Jump-financial

Coherus BioSciences (NASDAQ:CHRS) Receives Buy Rating from HC Wainwright

Coherus BioSciences (NASDAQ:CHRS) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los-angeles
California
United-states
Texas
Coherus-biosciences
Coherus-biosciences-company-profile
Barclays-plc
Mirae-asset-global-investments-co
Coherus-biosciences-inc
Los-angeles-capital-management
Free-report
Truist-financial

Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) PT at $40.63

Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) PT at $40.63
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Jeffrey-dierks
Unisuper-management-pty-ltd
Lazard-asset-management
Cantor-fitzgerald
Needham-company
Harmony-biosciences-holdings-inc
Nasdaq
Pricet-rowe-associates-inc
Hancock-whitney-corp
Janus-henderson-group
Harmony-biosciences-holdings

Arcus Biosciences, Inc. (NYSE:RCUS) Receives $41.25 Average Price Target from Analysts

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target […]

United-states
Juanc-jaen
Jennifer-jarrett
Decheng-capital
Dimensional-fund-advisors
Arcus-biosciences-inc
Vanguard-group-inc
Securities-exchange-commission
Arcus-biosciences
Get-free-report
Biosciences-stock-down
Exchange-commission

vimarsana © 2020. All Rights Reserved.